Parx Materials N.V. (PARPF) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Parx Materials N.V. (PARPF) trades at $0.0001. Parx Materials N. V. specializes in antibacterial and antimicrobial plastic solutions, holding a patented technology known as Saniconcentrate. Sector: Basic materials.
Price as of Aug 21, 2026 · Last analyzed: Mar 18, 2026Analyst Coverage for PARPF: PARPF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates PARPF against Basic Materials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
PARPF: 2/3 scored disciplines lean bearish. Dominant signal: Izzy Englander bullish.
How is this calculated? →Parx Materials N.V. (PARPF) Materials & Commodity Exposure
Parx Materials N.V. develops and sells antibacterial and antimicrobial plastic solutions globally, utilizing its patented Saniconcentrate technology. The company focuses on high-value applications in food packaging, medical devices, and textiles, offering a unique approach to material hygiene and preservation within the specialty chemicals sector.
What Is the Investment Thesis for PARPF?
Parx Materials N.V. presents a focused investment opportunity within the specialty chemicals sector, driven by increasing demand for antimicrobial solutions in various industries. The company's patented Saniconcentrate technology offers a unique selling proposition, potentially leading to increased market share in targeted applications. Growth catalysts include expanding partnerships with manufacturers in the food packaging and medical device industries. However, investors may want to evaluate the risks associated with operating in the OTC market and the company's relatively small size, which may impact liquidity and financial stability. Further research into the company's financial performance and market penetration is warranted.
Based on FMP financials and quantitative analysis
PARPF Key Highlights
Parx Materials N.V. operates in the antibacterial/antimicrobial plastics market, a growing segment within the specialty chemicals industry.
- The company's patented Saniconcentrate technology provides a competitive advantage in creating antimicrobial plastic solutions.
- Parx Materials serves diverse sectors including food packaging, medical devices, and textiles, reducing reliance on a single market.
- Headquartered in Rotterdam, the Netherlands, providing access to European markets and regulatory frameworks.
- The company's beta of 0.88 suggests lower volatility compared to the overall market.
Who Are PARPF's Competitors?
PARPF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| LIN Linde plc | $480.38 | -0.16% | $222B | 51 |
| SHW The Sherwin-Williams Company | $346.91 | -1.89% | $84.2B | 72 |
| ECL Ecolab Inc. | $281.48 | -1.45% | $79.2B | 67 |
| GVDNY Givaudan S.A. | $80.07 | +3.09% | $37.0B | 53 |
| NVZMY Novozymes A/S | $69.51 | +8.29% | $32.4B | 62 |
| PPG PPG Industries, Inc. | $112.44 | -1.30% | $25.0B | 78 |
| SQM Sociedad Química y Minera de Chile S.A. produces and distributes specialty plant nutrients, iodine and its derivatives, lithium and its derivatives, potassium chloride and sulfate, industrial chemicals, and other products and services. The company | $75.38 | +1.22% | $21.5B | 53 |
| IFF International Flavors & Fragrances Inc. | $83.33 | +2.88% | $21.3B | 53 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are PARPF's Key Strengths?
Patented Saniconcentrate technology.
- Diverse application areas (food, medical, textiles).
- Focus on a growing market segment (antimicrobial plastics).
- Experienced management team.
What Are PARPF's Weaknesses?
Small company size limits resources.
- OTC market listing may affect liquidity.
- Limited brand recognition compared to larger competitors.
- Dependence on a single core technology.
What Could Drive PARPF Stock Higher?
Potential partnerships with major food packaging companies to integrate Saniconcentrate technology.
- Expansion into new geographic markets, particularly in Asia and North America.
- Increasing demand for antimicrobial solutions due to hygiene concerns and regulatory requirements.
- Development of new applications for Saniconcentrate technology in various industries.
- Research and development efforts to enhance the performance and cost-effectiveness of antimicrobial plastics.
What Are the Key Risks for PARPF?
Negative return on equity (-5.6%) — the business is not currently generating profit on shareholder capital.
- Competition from larger chemical companies with greater resources.
- Regulatory changes affecting the use of antimicrobial plastics.
- Economic downturn impacting demand for specialty materials.
- Limited liquidity due to OTC market listing.
- Dependence on a single core technology (Saniconcentrate).
What Are the Growth Opportunities for PARPF?
- Expansion in the Food Packaging Industry: The increasing demand for safer and more hygienic food packaging solutions presents a significant growth opportunity for Parx Materials. Integrating Saniconcentrate technology into food packaging can extend shelf life and reduce the risk of contamination.
- Penetration of the Medical Device Market: The medical device industry requires stringent antimicrobial properties to prevent infections. Parx Materials' technology can be incorporated into medical devices and implants, reducing the risk of hospital-acquired infections. The global medical device market is a multi-billion dollar industry, and the demand for antimicrobial solutions is expected to grow, providing a strong growth avenue for Parx Materials.
- Growth in the Textile Industry: Incorporating antimicrobial plastics into textiles can prevent the growth of bacteria and fungi, enhancing hygiene and reducing odors. This is particularly relevant for sportswear, healthcare textiles, and protective clothing. The global textile market is vast, and the demand for antimicrobial textiles is increasing, offering a significant growth opportunity for Parx Materials.
- Strategic Partnerships and Collaborations: Forming strategic partnerships with manufacturers in various industries can accelerate the adoption of Parx Materials' technology. Collaborations with food packaging companies, medical device manufacturers, and textile producers can expand the company's reach and market penetration. These partnerships can provide access to established distribution networks and customer bases.
- Geographic Expansion: Expanding into new geographic markets, particularly in Asia and North America, can drive growth for Parx Materials. These regions have a high demand for antimicrobial solutions due to increasing awareness of hygiene and growing healthcare sectors. Establishing a presence in these markets through partnerships or direct investment can significantly increase the company's revenue and market share.
What Are PARPF's Competitive Advantages?
- Patented Saniconcentrate technology provides a competitive advantage.
- Focus on specialized applications creates a niche market position.
- Diverse customer base reduces reliance on a single industry.
- Expertise in antimicrobial plastics offers a barrier to entry.
What Does PARPF Do?
Parx Materials N.V., established in 2012 and headquartered in Rotterdam, the Netherlands, is a manufacturer and distributor of antibacterial and antimicrobial plastics. Originally named Parx Plastics N.V., the company rebranded in January 2020 to Parx Materials N.V. The company's core offering revolves around its patented Saniconcentrate technology, which is integrated into various plastic products to impart antibacterial and antimicrobial properties. These products find applications across diverse sectors, including food contact and packaging, medical devices and implants, textiles, pipes and drainages, and anti-fouling solutions. Parx Materials aims to prevent mold, material deterioration, and biofilm formation, thereby enhancing product lifespan and hygiene. The company's focus on innovation and specialized applications positions it within the niche market of antimicrobial material solutions.
What Products and Services Does PARPF Offer?
- Manufactures and sells antibacterial/antimicrobial plastics.
- Offers solutions for food contact applications and food packaging.
- Provides materials for medical devices and implants.
- Supplies antimicrobial plastics for textiles.
- Offers solutions for pipes and drainages.
- Develops anti-fouling and hygiene applications.
- Prevents mold and material deterioration.
- Reduces biofilm formation.
How Does PARPF Make Money?
- Develops and patents antimicrobial plastic technology (Saniconcentrate).
- Manufactures and sells antimicrobial plastic products.
- Partners with manufacturers to integrate its technology into their products.
- Targets diverse industries including food packaging, medical devices, and textiles.
What Industry Does PARPF Operate In?
Parx Materials N.V. operates within the specialty chemicals industry, specifically targeting the antimicrobial plastics market. This market is driven by increasing awareness of hygiene and the need to prevent bacterial growth in various applications. The competitive landscape includes both large chemical companies and smaller specialized firms. Parx Materials differentiates itself through its patented Saniconcentrate technology. The global antimicrobial plastics market is projected to grow, driven by demand from healthcare, food packaging, and consumer goods sectors.
Who Are PARPF's Key Customers?
- Food packaging manufacturers.
- Medical device and implant companies.
- Textile producers.
- Companies in the pipe and drainage industry.
- Businesses requiring anti-fouling and hygiene solutions.
Company Profile
Parx Materials N.V. operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in Rotterdam, NL. The company is led by CEO Michael van der Jagt. PARPF has traded publicly since 2020.
Key Financial Metrics
Return on equity for Parx Materials N.V. stands at -5.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -6.1%, showing how much profit it generates from its asset base. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 73.08 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -3.0%, the inverse of the P/E and a quick read on earnings relative to price.
PARPF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Patented Saniconcentrate technology.
- Diverse application areas (food, medical, textiles).
- Focus on a growing market segment (antimicrobial plastics).
- Experienced management team.
Bear Case
- Small company size limits resources.
- OTC market listing may affect liquidity.
- Limited brand recognition compared to larger competitors.
- Dependence on a single core technology.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
PARPF Latest News
No recent news available for PARPF.
PARPF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for PARPF.
Price Targets
Wall Street price target analysis for PARPF.
PARPF MoonshotScore
What does this score mean?
The MoonshotScore rates PARPF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Michael van der Jagt
CEO
Michael van der Jagt serves as the CEO of Parx Materials N.V. His professional background includes experience in the materials science and plastics industries. He has held various leadership positions focused on business development, strategic planning, and market expansion. His expertise lies in commercializing innovative technologies and building partnerships to drive growth. He is responsible for the overall strategic direction and operational execution of Parx Materials.
Track Record: Under Michael van der Jagt's leadership, Parx Materials N.V. has focused on expanding the application of its Saniconcentrate technology across various sectors, including food packaging and medical devices. He has overseen the company's efforts to secure partnerships and collaborations to increase market penetration. Key milestones include the rebranding of the company to Parx Materials N.V. and the continued development of its patented technology.
PARPF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Parx Materials N.V. may not meet the minimum financial or reporting standards required for higher tiers like OTCQB or OTCQX. Companies in this tier may have limited information available to investors and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for limited liquidity and transparency.
- OTC Tier: OTC Other
- Limited liquidity due to lower trading volumes on the OTC market.
- Higher price volatility compared to stocks listed on major exchanges.
- Less stringent reporting requirements, potentially leading to less transparency.
- Potential for limited access to company information and management.
- Increased risk of fraud or manipulation due to less regulatory oversight.
- Verify the company's financial statements and disclosures.
- Research the management team and their experience.
- Assess the company's competitive position and market opportunity.
- Understand the risks associated with investing in an OTC-listed stock.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- Confirm the legitimacy of the company's operations and assets.
- Patented Saniconcentrate technology provides a unique selling proposition.
- Serving diverse industries including food packaging, medical devices, and textiles.
- Experienced management team with a background in materials science.
- Headquartered in Rotterdam, the Netherlands, a reputable business location.
- Focus on developing innovative antimicrobial solutions.
Parx Materials N.V. Basic Materials Stock: Key Questions Answered
What does Parx Materials N.V. do?
Parx Materials N.V. specializes in the development, manufacturing, and sale of antibacterial and antimicrobial plastic solutions. The company's core technology, Saniconcentrate, is a patented method for incorporating antimicrobial properties into plastics, making them suitable for use in various applications.
What do analysts say about PARPF stock?
As of March 18, 2026, there is no readily available analyst consensus on PARPF stock due to its listing on the OTC market and relatively small market capitalization. Investors should conduct their own due diligence and consider factors such as the company's patented technology, growth potential in the antimicrobial plastics market, and risks associated with OTC-listed stocks.
What are the main risks for PARPF?
The main risks for Parx Materials N.V. include its reliance on a single core technology (Saniconcentrate), which could be vulnerable to competition from alternative antimicrobial solutions. As an OTC-listed stock, PARPF faces liquidity risks and potential price volatility. The company also operates in a competitive market with larger chemical companies, which could limit its market share.
What are the key factors to evaluate for PARPF?
Evaluate PARPF on fundamentals, analyst consensus, and risk factors. Parx Materials N.V. presents a focused investment opportunity within the specialty chemicals sector, driven by increasing demand for antimicrobial solutions in various industries. Not financial advice.
How frequently does PARPF data refresh on this page?
PARPF's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven PARPF's recent stock price performance?
Parx Materials N.V. (PARPF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Patented Saniconcentrate technology. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider PARPF overvalued or undervalued right now?
Parx Materials N.V. (PARPF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research PARPF before investing?
Before investing in Parx Materials N.V. (PARPF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- OTC market stocks carry higher risks than exchange-listed stocks.